AGI-14100

AGI-14100 is a metabolically stable and orally available mIDH1 inhibitor (IC50=6 nM). The pharmacochemical optimization of AGI-14100 is aimed at eliminating hPXR activation, resulting in the final drug candidate AG-120. AG-120 can be used in the study of cancers carrying IDH1 mutations. The discovery and development of AGI-14100 can be used for further studies of mutant isocitrate dehydrogenase 1 (mIDH1) inhibitors.

For research use only. We do not sell to patients.

  • CAS No.: 1448346-43-7
  • Formula: C29H22ClF4N5O3
  • Molecular Weight:599.96
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Isocitrate Dehydrogenase (IDH) Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Price: USD 0.00